4//SEC Filing
Poole Jonathan 4
Accession 0001694665-20-000002
CIK 0001694665other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:14 PM ET
Size
7.5 KB
Accession
0001694665-20-000002
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (Right to Buy)
2020-01-28+106,000→ 106,000 totalExercise: $7.06Exp: 2030-01-27→ Common Stock (106,000 underlying) - Award
Stock Option (Right to Buy)
2020-01-28+48,000→ 48,000 totalExercise: $7.06Exp: 2030-01-27→ Common Stock (48,000 underlying)
Footnotes (2)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of January 9, 2020, subject to continued employment on such dates.
- [F2]These options will vest as to 50% of the total grant on January 9, 2022 and as to the remaining 50% on January 9, 2023.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001604689
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:14 PM ET
- Size
- 7.5 KB